304 related articles for article (PubMed ID: 27889812)
1. Research progress of hydroxychloroquine and autophagy inhibitors on cancer.
Shi TT; Yu XX; Yan LJ; Xiao HT
Cancer Chemother Pharmacol; 2017 Feb; 79(2):287-294. PubMed ID: 27889812
[TBL] [Abstract][Full Text] [Related]
2. Targeting Autophagy in Cancer: Update on Clinical Trials and Novel Inhibitors.
Chude CI; Amaravadi RK
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28621712
[TBL] [Abstract][Full Text] [Related]
3. Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy.
Peng X; Zhang S; Jiao W; Zhong Z; Yang Y; Claret FX; Elkabets M; Wang F; Wang R; Zhong Y; Chen ZS; Kong D
J Exp Clin Cancer Res; 2021 Nov; 40(1):374. PubMed ID: 34844627
[TBL] [Abstract][Full Text] [Related]
4. Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis.
Lin YC; Lin JF; Wen SI; Yang SC; Tsai TF; Chen HE; Chou KY; Hwang TI
Kaohsiung J Med Sci; 2017 May; 33(5):215-223. PubMed ID: 28433067
[TBL] [Abstract][Full Text] [Related]
5. Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency.
McAfee Q; Zhang Z; Samanta A; Levi SM; Ma XH; Piao S; Lynch JP; Uehara T; Sepulveda AR; Davis LE; Winkler JD; Amaravadi RK
Proc Natl Acad Sci U S A; 2012 May; 109(21):8253-8. PubMed ID: 22566612
[TBL] [Abstract][Full Text] [Related]
6. Addition of rapamycin and hydroxychloroquine to metronomic chemotherapy as a second line treatment results in high salvage rates for refractory metastatic solid tumors: a pilot safety and effectiveness analysis in a small patient cohort.
Chi KH; Ko HL; Yang KL; Lee CY; Chi MS; Kao SJ
Oncotarget; 2015 Jun; 6(18):16735-45. PubMed ID: 25944689
[TBL] [Abstract][Full Text] [Related]
7. Chloroquine and hydroxychloroquine in antitumor therapies based on autophagy-related mechanisms.
Ferreira PMP; Sousa RWR; Ferreira JRO; Militão GCG; Bezerra DP
Pharmacol Res; 2021 Jun; 168():105582. PubMed ID: 33775862
[TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine potentiates the anti-cancer effect of bevacizumab on glioblastoma via the inhibition of autophagy.
Liu LQ; Wang SB; Shao YF; Shi JN; Wang W; Chen WY; Ye ZQ; Jiang JY; Fang QX; Zhang GB; Xuan ZX
Biomed Pharmacother; 2019 Oct; 118():109339. PubMed ID: 31545270
[TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine: A Physiologically-Based Pharmacokinetic Model in the Context of Cancer-Related Autophagy Modulation.
Collins KP; Jackson KM; Gustafson DL
J Pharmacol Exp Ther; 2018 Jun; 365(3):447-459. PubMed ID: 29438998
[TBL] [Abstract][Full Text] [Related]
10. Induction of cytosine arabinoside-resistant human myeloid leukemia cell death through autophagy regulation by hydroxychloroquine.
Kim Y; Eom JI; Jeung HK; Jang JE; Kim JS; Cheong JW; Kim YS; Min YH
Biomed Pharmacother; 2015 Jul; 73():87-96. PubMed ID: 26211587
[TBL] [Abstract][Full Text] [Related]
11. Indentification of breast cancer subtypes sensitive to HCQ-induced autophagy inhibition.
Wang P; Du Y; Wang J
Pathol Res Pract; 2019 Oct; 215(10):152609. PubMed ID: 31488317
[TBL] [Abstract][Full Text] [Related]
12. Significantly enhanced tumor cellular and lysosomal hydroxychloroquine delivery by smart liposomes for optimal autophagy inhibition and improved antitumor efficiency with liposomal doxorubicin.
Wang Y; Shi K; Zhang L; Hu G; Wan J; Tang J; Yin S; Duan J; Qin M; Wang N; Xie D; Gao X; Gao H; Zhang Z; He Q
Autophagy; 2016 Jun; 12(6):949-62. PubMed ID: 27123811
[TBL] [Abstract][Full Text] [Related]
13. ALDH1A1 and HLTF modulate the activity of lysosomal autophagy inhibitors in cancer cells.
Piao S; Ojha R; Rebecca VW; Samanta A; Ma XH; Mcafee Q; Nicastri MC; Buckley M; Brown E; Winkler JD; Gimotty PA; Amaravadi RK
Autophagy; 2017; 13(12):2056-2071. PubMed ID: 28981387
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells.
Rahim R; Strobl JS
Anticancer Drugs; 2009 Sep; 20(8):736-45. PubMed ID: 19584707
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine induces autophagic cell death of human dermal fibroblasts: implications for treating fibrotic skin diseases.
Oikarinen A
J Invest Dermatol; 2009 Oct; 129(10):2333-5. PubMed ID: 19749781
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and Pharmacodynamic Assessment of Hydroxychloroquine in Breast Cancer.
Van Eaton KM; Gustafson DL
J Pharmacol Exp Ther; 2021 Dec; 379(3):331-342. PubMed ID: 34503992
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in targeting autophagy in cancer.
Jain V; Singh MP; Amaravadi RK
Trends Pharmacol Sci; 2023 May; 44(5):290-302. PubMed ID: 36931971
[TBL] [Abstract][Full Text] [Related]
18. Subcellular localization of FOXO3a as a potential biomarker of response to combined treatment with inhibitors of PI3K and autophagy in PIK3CA-mutant cancer cells.
Kim HJ; Lee SY; Kim CY; Kim YH; Ju W; Kim SC
Oncotarget; 2017 Jan; 8(4):6608-6622. PubMed ID: 28036259
[TBL] [Abstract][Full Text] [Related]
19. Autophagy Agents in Clinical Trials for Cancer Therapy: A Brief Review.
Mohsen S; Sobash PT; Algwaiz GF; Nasef N; Al-Zeidaneen SA; Karim NA
Curr Oncol; 2022 Mar; 29(3):1695-1708. PubMed ID: 35323341
[TBL] [Abstract][Full Text] [Related]
20. A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors.
Mehnert JM; Kaveney AD; Malhotra J; Spencer K; Portal D; Goodin S; Tan AR; Aisner J; Moss RA; Lin H; Bertino JR; Gibbon D; Doyle LA; White EP; Stein MN
Cancer Chemother Pharmacol; 2019 Oct; 84(4):899-907. PubMed ID: 31463691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
